Affected individuals from four families with compound heterozygous pathogenic variants in SCN4A were reported to have symptoms of a congenital myopathy, and all were noted to have mild to moderate facial weakness that was either present at birth (3 of 4 families with CFW) or developed during the first few days of life (1 family). The gene discussed is SCN4A; the disease is congenital myopathy.